Ticker
HRTXCompany Name
HERON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 202.35M | $ 1.28M | $ 0 | $ 0 | -0.63% |
3/31/2025 | $ 369.2M | $ 993K | $ 0 | $ 0 | -0.27% |
12/31/2024 | $ 312.28M | $ 940K | $ 0 | $ 0 | -0.3% |
9/30/2024 | $ 194.68M | $ 716K | $ 0 | $ 0 | -0.37% |
6/30/2024 | $ 404.95M | $ 30.15M | $ 24.35M | $ 0 | -13.46% |
3/31/2024 | $ 432.37M | $ 29.98M | $ 24.35M | $ 0 | -12.56% |
12/31/2023 | $ 354.78M | $ 29.76M | $ 24.35M | $ 0 | -15.25% |
9/30/2023 | $ 81.04M | $ 30M | $ 24.35M | $ 0 | -67.06% |
6/30/2023 | $ 212.55M | $ 75.49M | $ 0 | $ 0 | -35.52% |
3/31/2023 | $ 266.96M | $ 75.49M | $ 0 | $ 0 | -28.28% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for HERON THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 168.47M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 1.57B ]
(=) Shareholder Yield [ -10.75% ]
Minimum
Sep 30, 2023
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.56% |
median | 1.07% |
std | 11.12% |